Search

everythinglearnresearchcommunity

for

Search:↓

Mesenchymal stem cell therapy shows promise for treating certain inflammatory skin diseases, but more research is needed.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Plant compounds may boost antiviral treatments.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Immune therapy for cancer can cause rare hair loss but doesn't stop treatment success.

New therapies targeting skin neuroimmune interactions could treat neuropathic pain.

A specific group of immune and skin cells may cause chronic inflammation in atopic dermatitis.

Caloric stress and differentiation increase IRES translation, affecting stem cell function and potential therapies.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

STIM1 is essential for sweat secretion.

Panax notoginseng saponins with stem cells improve healing and reduce inflammation in diabetic ulcers.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Hair follicle cells help protect against immune attacks by regulating T-cell activity.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Small molecule IM boosts hair growth by changing stem cell metabolism.

The medium from stem cells in fat tissue may boost hair growth.

The ID2 gene can help distinguish between sensitizers and irritants in skin cells.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Thymosin beta 4 protects cells from damage by blocking a harmful microRNA and boosting a protective gene.

Ovalbumin–aluminum sensitization causes increased pain sensitivity and nerve changes in mice.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

The role of γδT-cells in causing alopecia areata remains unclear.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

ADSCs help protect skin from UV damage and aging.